Follow The Filings

WULF TeraWulf

TeraWulf earnings company data as of 4:00 PM ET 11/8

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS -0.38 -0.03 Beat
Rev $63.3M $76.2M Beat +20.3%

Insider trades

Open-market buys and sales by WULF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WULF insider trades
  • $440K bought by 1 insider
  • $17.2M sold by 4 insiders outside a trading plan
  • $18.9M sold by 1 insider under 10b5-1 plans
  1. Michael C. Bucella Director
    Buy
    $90K 6,085 shares at $14.79 +1.8% to stake
    Traded Sep 15 Filed Sep 16
    ↗
  2. Catherine J. Motz Director
    Sale
    $998K 56,023 shares at $17.81 27% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  3. Walter E. Carter Director
    Sale
    $2M 130,626 shares at $15.14 36% of stake
    Traded Aug 31 Filed Sep 1
    ↗
  4. Paul B. Prager CEO
    Planned sale
    $2.3M 137,500 shares at $17.06 3.5% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  5. Michael C. Bucella Director
    Buy
    $100K 5,883 shares at $16.99 +1.7% to stake
    Traded Aug 14–17 Filed Aug 17
    ↗
  6. Paul B. Prager CEO
    Planned sale
    $3.7M 137,500 shares at $26.60 3.4% of stake
    Traded Jun 29 Filed Jul 1
    ↗
  7. Paul B. Prager CEO
    Planned sale
    $8.4M 333,300 shares at $25.17 7.5% of stake
    Traded May 26–27 Filed May 28
    ↗
  8. Paul B. Prager CEO
    Sale
    $4.5M 216,700 shares at $20.73 20% of stake
    Traded Apr 27–28 Filed Apr 28
    ↗
  9. Paul B. Prager CEO
    Planned sale
    $4.5M 275,000 shares at $16.53 56% of stake
    Traded Mar 24–25 Filed Mar 25
    ↗
  10. Michael C. Bucella Director
    Buy
    $25K 1,665 shares at $15.04 +0.6% to stake
    Traded Mar 20 Filed Mar 20
    ↗
  11. Michael C. Bucella Director
    Buy
    $75K 4,835 shares at $15.57 +1.8% to stake
    Traded Mar 17–19 Filed Mar 19
    ↗
  12. Patrick Fleury CFO
    Sale
    $9.7M 600,000 shares at $16.14
    Traded Mar 17 Filed Mar 19
    ↗
  13. Michael C. Bucella Director
    Buy
    $20K 1,338 shares at $14.91 +0.5% to stake
    Traded Mar 11 Filed Mar 13
    ↗
  14. Michael C. Bucella Director
    Buy
    $30K 2,085 shares at $14.42 +0.8% to stake
    Traded Mar 5–9 Filed Mar 9
    ↗
  15. Michael C. Bucella Director
    Buy
    $50K 3,171 shares at $15.78 +1.2% to stake
    Traded Mar 4 Filed Mar 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 18 sales back to the company, 11 stock grants, 4 other transactions, 1 gift, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 1.01,7.01,8.01,9.01 Filing Doc
8-K 1.01,2.03 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf